Učitavanje...
Recommendations to Facilitate Expanded Access to Investigational Therapies for Seriously Ill Patients
When clinical trial enrollment is not an option for seriously ill patients whose illnesses have not responded to approved treatment options, those patients and their physicians may consider gaining access to investigational therapies through a pathway established by the Food and Drug Administration...
Spremljeno u:
| Izdano u: | Acad Med |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4767550/ https://ncbi.nlm.nih.gov/pubmed/26445080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/ACM.0000000000000914 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|